Overview of How Glp 1 Can Help In Treating Addiction Disorders

A popular class of therapies for treating diabetes and obesity may also have the potential to treat alcohol and drug addiction , according to a new paper published in the Journal of the Endocrine Society. The therapies, known as Glucagon-Like Peptide-1 Receptor Agonists ( GLP -1RAs), present an encouraging approach to treating alcohol and other substance use disorders . "Early research in both ...

The Food and Drug Administration has approved GLP-1 medications for treating type 2 diabetes and obesity. Some doctors are prescribing these drugs off-label for a variety of addictive disorders . Research is under way on the effectiveness of treating addiction with these medications, and some initial studies have shown promising results.
The role of glucagonlike peptide 1 (GLP1) in addictive disorders

Glucagon‐like peptide 1 ( GLP‐1 ) is released in the small intestine, promotes blood glucose homeostasis, slows gastric emptying and reduces appetite. GLP‐1 receptor agonists approved for treating Type 2 diabetes mellitus and obesity have received attention as a potential anti‐addiction treatment.
Clinical trials suggest Ozempic and Other GLP-1s may treat alcohol, opioid and nicotine addiction by rewiring the brain's reward system. Learn about the science, risks and off-label use.

The potential role of GLP
These findings imply that different GLP-1 receptor agonists might have differential efficacy across various substance use disorders , being more effective in treating alcohol and nicotine addiction but less so for opioid addiction .
The GLP-1 class of diabetes and obesity drugs show promise in treating and preventing all substance use disorders in a new study.

Overview of How Glp 1 Can Help In Treating Addiction Disorders
A popular class of therapies for treating diabetes and obesity may also have the potential to treat alcohol and drug addiction , according to a new paper published in the Journal of the Endocrine Society. The therapies, known as Glucagon-Like Peptide-1 Receptor Agonists ( GLP -1RAs), present an encouraging approach to treating alcohol and other substance use disorders . "Early […]
This has led addiction scientists to take an interest in GLP-1 agonists as a potential addiction treatment. A new study of adults with alcohol use disorders found that semaglutide reduced alcohol ...

Key Details About How Glp 1 Can Help In Treating Addiction Disorders
Researchers have discovered that drugs like Ozempic for diabetes and obesity also improve alcohol use disorders and other addictions . This is a stunning gut-brain breakthrough.




This systematic review of clinical trials focusing on glucagon-like peptide-1 receptor agonists ( GLP -1RAs) for the treatment of substance use disorders (SUDs) has several important findings.